Considering Phase I (US) trial for BGB-11417 - CLL Support
Considering Phase I (US) trial for BGB-11417
You need to be a member of this community to see this post.
Read more about...
22 Replies
You need to be a member of this community to see hidden responses.
Not what you're looking for?
You may also like...
Clinical Trial with BGB-11417
read, BGB-11417 is more selective for BCL-2, has less side effects and is extremely effective....
2nd gen BCL-2 inhibitor in trials and looking promising -- Sonrotoclax (BGB-11417)
m_BGB-11417-101_ASH_Presentation_2023.pdf
This is a combo trial, sonrotoclax and Zanubrutinib on...
Zanubrutinib, Obinutuzumab and Venetoclax. Front line Clinical Trial.
month ago. Zanubrutinib tabs 160 mg BID with no negative reactions so far. This drug is not FDA...
Anyone attend Mayo clinic phase II trial of EGCG on CLL?
results from Mayo clinic phase II trial of EGCG on CLL patients. However, the trial finished in 6...
Zanubrutinib / BGB-3111
or try to get into Clinical Trial with BGB-3111/ Zanubrutinib, new BTKi drug from China. Does...